PIRAMAL PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 158 INR | +0.40% |
|
+0.48% | +13.78% |
| May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
| May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
Chart calendar Piramal Pharma Limited
d9cf7ddd645fb5fb06d.Ury_LLbH57l-DnaHuJjO9NVAu3_VjaxfHXH6ZiO-D4U.JunOb-ydheYrSBuyyqz5nrAw2QW0tO4IWESiBWnvfMI-iY0awIa04TV9Nw~b996659e7140b51d01b12879f800e17c
Upcoming events on Piramal Pharma Limited
Past events on Piramal Pharma Limited
| 2024-06-17 | Nuvama Speciality Chemicals & Healthcare Day |
| 2024-06-09 | Investor Meeting - Goldman Sachs India Securities Ltd |
| 2024-06-06 | Titans of Tomorrow Conference |
| 2024-06-04 | Nomura Asia Investment Forum |
| 2024-05-13 12:00 am | Q4 2024 Earnings Call |
| 2024-05-10 11:01 am | Q4 2024 Earnings Release |
| 2024-03-18 | Motilal Oswal India Ideation Conference |
| 2024-03-11 | Investor Meeting - Day 2 |
| 2024-03-10 | Investor Meeting - Day 1 |
| 2024-03-03 | Investor Meeting - Macquarie |
| 2024-02-28 | Investec Promoter & Founder Conference |
| 2024-02-27 | Investor Meeting - BofA Securities |
| 2024-01-31 06:30 am | Q3 2024 Earnings Call |
| 2024-01-30 10:22 am | Q3 2024 Earnings Release |
| 2024-01-09 | Investor Meeting - Day 3 |
| 2024-01-08 | Investor Meeting - Day 2 |
| 2024-01-07 | Investor Meeting - Day 1 |
| 2023-12-17 | Investor Meeting - Kotak Securities |
| 2023-12-11 | Investor Meeting - Equirus Securities |
| 2023-12-04 | Nuvama Emerging Ideas Conference |
Annual results
| Fiscal Period | March | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 0,00 | 70 816 69 704 1.59% | 81 712 81 131 0.72% | 91 753 |
|
EBITDA Million INR | Released Forecast Spread | 0,00 | 6 282 5 726 9.71% | 11 963 11 167 7.12% | 14 008 |
|
EBIT Million INR | Released Forecast Spread | 0,00 | -485 -1 193 59.38% | 4 557 3 846 18.5% | 5 941 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 0,00 | -1 202 -1 099 -9.38% | 1 793 1 335 34.3% | 3 334 |
|
Net income Million INR | Released Forecast Spread | 3 760 | -1 865 -1 899 1.84% | 178 1 178 -84.87% | 2 233 |
|
EPS INR | Released Forecast Spread | 3,19 | -1,57 -1,00 -57% | 0,14 0,75 -81.33% | 1,71 |
| Announcement Date | 24/05/22 | 24/05/23 | 10/05/24 | - |
Quarterly results
| Fiscal Period | Marzo | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 17 160 17 922 -4.25% | 21 636 21 095 2.56% | 17 489 17 125 2.13% | 19 114 19 257 -0.75% | 19 586 20 066 -2.39% | 25 524 24 785 2.98% | |
|
EBITDA Million INR | Released Forecast Spread | 873 2 289 -61.84% | 3 513 2 700 30.12% | 1 323 1 398 -5.35% | 2 656 2 232 19.01% | 2 684 3 011 -10.88% | 5 299 4 498 17.83% | |
|
EBIT Million INR | Released Forecast Spread | -771 665 -215.94% | 1 669 184 806.85% | -413 -516 19.98% | 811 498 62.91% | 821 1 307 -37.22% | 3 338 3 099 7.71% | |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | -736 430 -271.26% | 949 48,0 1876.88% | -1 071 -1 116 4.02% | 396 348 13.68% | 194 1 067 -81.86% | 2 275 2 761 -17.61% | |
|
Net income Million INR | Released Forecast Spread | -373 | -902 400 -325.45% | 501 157 219.17% | -986 -1 116 11.67% | 50,2 24,5 104.9% | 101 832 -87.85% | 1 013 1 970 -48.59% |
|
EPS INR | Released Forecast Spread | -0,31 | 0,04 | |||||
| Announcement Date | 09/11/22 | 08/02/23 | 24/05/23 | 03/08/23 | 27/10/23 | 30/01/24 | 10/05/24 |
| 2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
| 2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
| 2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
| 2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
| 2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
| 2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Piramal Pharma Limited
| 2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
| 2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
| 2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PPLPHARMA Stock
- Calendar Piramal Pharma Limited
